Leadership
Unlimited Heart Health & Wellness founder Jim Kaveney discusses the platform he is developing for atrial fibrillation patients and their caretakers and his goal of partnering with patient advocacy groups, nonprofits and healthcare systems in the future.
FinThrive SVP and CISO Greg Surla discusses why providers should not rely on single vendors in RCM environments and how the Change Healthcare attack was a watershed moment.
HIMSS24
Dr. Nada Milosavljevic, Safe Health CMO and 2024 HIMSS Changemaker Award recipient, offers advice on collaborating with people from different backgrounds and becoming comfortable with challenges while working in the healthcare innovation space.
HIMSS24
Oscar Alleyne, managing director of the public health division at MITRE, relays how federally funded research and development centers help public and private companies solve complex problems, including preparing for the next pandemic.
The ONC's new rules could include advancements around public health IT certification requirements, electronic prior authorization, patient engagement tools and refinement to info blocking rules, says Sean Sullivan, a partner at Alston & Bird.
Carolyn Metnick, partner and Healthcare and Privacy & Cybersecurity team member at Sheppard Mullin, recommends that healthcare organizations follow basics such as following HIPAA security rule compliance and doing a security risk analysis.
HIMSS24
Sales Director at CenTrak and South Florida HIMSS president Kendall Brown talks about the bridge between her sales experience and state-policy advocacy.
HIMSS24
Dr. Donald Warne, codirector of the Center for Indigenous Health at the Johns Hopkins Bloomberg School of Public Health, advocates for the recognition of Indigenous medical contributions, including osteopathy’s origin in Shawnee and Otoe practices.
HIMSS24
Dr. Brian Anderson, CEO, Coalition of Health AI (CHAI), shares the challenges of developing specifications and ethical standards for still-evolving AI technology, as well as how members ensure patient safety remains at the center of discussions.
Clinical-trial research company Clario announces new hire, and AI-enabled surgical care organization Apella and data company Brillio announce additions to their board of directors.